RMTI Rockwell Medical Inc.

3.15
+0.14  (+5%)
Previous Close 3.01
Open 3.02
Price To Book 14.32
Market Cap 179479616
Shares 56,977,656
Volume 146,999
Short Ratio
Av. Daily Volume 191,664

SEC filingsSee all SEC filings

  1. EFFECT - Notice of Effectiveness 181215315
  2. 8-K - Current report 181209090
  3. CT ORDER - Confidential treatment order 181194415
  4. S-3 - Registration statement under Securities Act of 1933 181190171
  5. 8-K - Current report 181174618

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Iron deficiency
NDA filing due 4Q 2018.
IV Triferic
Iron deficiency (Kidney disease)

Latest News

  1. Edited Transcript of RMTI earnings conference call or presentation 9-Nov-18 1:30pm GMT
  2. Report: Developing Opportunities within Eaton Vance, IDT, Hemispherx BioPharma, Edgewell Personal Care, Rockwell Medical, and Avadel Pharmaceuticals — Future Expectations, Projections Moving into 2018
  3. Rockwell Medical, Inc. Appoints New Vice President, Operations
  4. Rockwell Medical, Inc. Appoints New Vice President, Marketing
  5. Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
  6. Rockwell Medical: 3Q Earnings Snapshot
  7. Rockwell Medical, Inc. Reports Third Quarter 2018 Financial Results
  8. Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
  9. Rockwell Medical Appoints New Chief Financial Officer
  10. Rockwell Medical Schedules Third Quarter 2018 Conference Call
  11. Detailed Research: Economic Perspectives on Rockwell Medical, Diamondback Energy, Steven Madden, Synaptics, Photronics, and Caleres — What Drives Growth in Today's Competitive Landscape
  12. Rockwell Medical Announces Financing Transaction
  13. Rockwell Medical Provides Update on IV Triferic
  14. Edited Transcript of RMTI earnings conference call or presentation 14-Aug-18 9:00pm GMT
  15. Rockwell Medical Appoints VP, Strategic Accounts
  16. DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Rockwell Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  17. Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Rockwell Medical, Inc. (RMTI)
  18. DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Rockwell Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  19. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rockwell Medical, Inc. of Class Action Lawsuit and Upcoming Deadline - RMTI
  20. CLASS ACTION UPDATE for RMTI, TTPH, HMNY and GDS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

SEC Filings

  1. EFFECT - Notice of Effectiveness 181215315
  2. 8-K - Current report 181209090
  3. CT ORDER - Confidential treatment order 181194415
  4. S-3 - Registration statement under Securities Act of 1933 181190171
  5. 8-K - Current report 181174618
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181173964
  7. 8-K - Current report 181157441
  8. D - Notice of Exempt Offering of Securities 181145633
  9. 8-K - Current report 181130779
  10. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 181127011